certepetide
·Code: LSTA1, CEND-1
certepetide: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| LISATA THERAPEUTICS, INC. (LSTA) | Phase 2 |
Clinical Trials (1)
A Phase 2a, Double-blind, Placebo-controlled, Multi-center, Randomized Study Evaluating LSTA1 When Added to Standard of Care (SoC) Versus Standard of Care Alone in Subjects With Advanced Solid Tumors (BOLSTER)
Frequently asked questions
Who is developing certepetide?
certepetide is being developed by LISATA THERAPEUTICS, INC..
How many clinical trials involve certepetide?
BioSniper tracks 1 clinical trial involving certepetide.
Get deeper analysis on certepetide
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis